May 27, 2017 7:06 AM ET


Company Overview of CollaGenex Pharmaceuticals, Inc.

Company Overview

CollaGenex Pharmaceuticals, Inc. develops and markets medical therapies for the dermatology market. Its lead development candidates include COL-118, a topical compound for the treatment of erythema (skin redness) associated with dermatological conditions; becocalcidiol, a vitamin D analogue, which is in a Phase II dose-finding clinical trial for the topical treatment of psoriasis; and Restoraderm, a proprietary foam-based, topical dermal drug delivery system. The company offers Oracea for the treatment of inflammatory lesions (papules and pustules) of rosacea in adult patients; Alcortin, a prescription topical antifungal steroid combination; and Novacort, a prescription topical steroid and a...

41 University Drive

Newtown, PA 18940

United States

Founded in 1992

147 Employees





Key Executives for CollaGenex Pharmaceuticals, Inc.

Vice President, Secretary and Director
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CollaGenex Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at